Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 ...

Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a ...

Investing.com -- Eli Lilly stock dropped 5% on Wednesday after rival Novo Nordisk announced disappointing results from its ...

Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because a volunteer has suffered a ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...

Stream Connecticut News for free, 24/7, wherever you are. The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific Sessions meeting ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

UnitedHealth Group is working with Eli Lilly on a clinical trial that will study at-home infusions of the drugmaker’s COVID-19 antibody treatment. Eli Lilly’s antibody drug, bamlanivimab, has received ...

Bernstein just threw fresh fuel on Eli Lilly's (LLY) never-ending rally, as the firm lifted its price target on the stock to ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The ...